Skip to main content
LIVE CIN BRIEFING
Macro: Cautious · Global: Expanding · Opportunities: Selective · CMHI: 28.9

International Cannabis Data

Cannabis markets across 13 countries — prevalence, economic indicators, and regulatory status from World Bank data.

View Country Data ↓
SIGNALS
GLOBAL

Germany Legalization Driving EU Momentum

Largest European market opening creating cross-border opportunities

BULLISH

Four New Markets Open in 2026

Expanding addressable market for international operators

REGULATORY

UN Treaty Modernization Discussions Advancing

International framework evolving to accommodate legal markets

MACRO

Cross-Border Capital Flows Accelerating

International investors increasing allocation to cannabis sector

Data loading…
219M Global Cannabis Users
4.3% Global Prevalence (15–64)
5,600t Annual Seizures
Source: UNODC World Drug Report 2024

Regional Prevalence

Cannabis-Legal Countries: Economic Indicators

Country GDP/Cap (USD) Population Health Exp. (% GDP) Unemployment (%) Trade (% GDP)
Loading World Bank data…
Complimentary Research
Would you like an international market report?

Request a complimentary, fully customized analysis of regulatory timelines, market sizing, and cross-border investment opportunities — tailored to the regions and markets you’re evaluating.

Request Complimentary Report

Terminal Dashboards

Disclaimer: Cannabis Investor News is for informational purposes only—not investment advice. We are not registered with the SEC, FINRA, or any regulatory body. Data may be delayed or inaccurate. Cannabis securities carry significant risk; you could lose your entire investment. Always consult a licensed financial advisor and verify all information independently before making any investment decision.

Global Cannabis Data — International Markets and Policy Tracker

Track international cannabis market developments, regulatory frameworks, and cross-border data with CIN's Global Cannabis dashboard. The global cannabis industry extends far beyond North America, with active medical and recreational markets in Germany, Australia, Israel, Thailand, Colombia, and other jurisdictions advancing cannabis legalization and commercialization.

CIN's global coverage monitors key international cannabis markets including Canada's mature recreational market (the world's largest legal cannabis market by revenue), Germany's emerging adult-use framework, and Australia's expanding medical cannabis program. Export data tracks Canadian cannabis shipment volumes, which have doubled annually as international demand grows and domestic oversupply drives producers to seek foreign markets. International cannabis policy developments directly impact publicly traded cannabis companies with global operations. Companies like Tilray Brands, Organigram, and Aurora Cannabis derive significant revenue from international medical cannabis markets. Policy changes in major markets — such as Germany's 2024 adult-use legalization or the United Kingdom's evolving medical cannabis framework — create investment catalysts that CIN tracks and analyzes.

The global dashboard also covers international cannabis regulatory bodies, trade agreements affecting cannabis commerce, and emerging market opportunities in Latin America, Southeast Asia, and Africa where cannabis legalization is progressing. Understanding global cannabis dynamics provides essential context for evaluating companies with international operations and export strategies.